144 related articles for article (PubMed ID: 30165212)
1. Prognostic Analysis of Clinical and Immunohistochemical Factors for Patients with Spinal Schwannoma.
Li B; Li J; Miao W; Zhao Y; Jiao J; Wu Z; Yang X; Wei H; Xiao J
World Neurosurg; 2018 Dec; 120():e617-e627. PubMed ID: 30165212
[TBL] [Abstract][Full Text] [Related]
2. Long-term postoperative outcomes of spinal cellular schwannoma: study of 93 consecutive cases.
Jia Q; Lou Y; Chen D; Li X; Liu Y; Chu R; Wang T; Zhou Z; Li D; Wan W; Huang Q; Yang X; Wang T; Wu Z; Xiao J
Spine J; 2024 May; 24(5):858-866. PubMed ID: 38272127
[TBL] [Abstract][Full Text] [Related]
3. Clinical Features and Prognostic Factors of Patients With Nerve Sheath Tumors in the Cervical Spine.
Li B; Yin H; Meng T; Zhou P; Han Z; Jia Q; Cai W; Han S; Wang T; Chen T; Zhou W; Xiao J
Spine (Phila Pa 1976); 2016 Oct; 41(20):E1208-E1215. PubMed ID: 27043192
[TBL] [Abstract][Full Text] [Related]
4. Malignant peripheral nerve sheath tumor of intracranial nerve: a case series review.
Ziadi A; Saliba I
Auris Nasus Larynx; 2010 Oct; 37(5):539-45. PubMed ID: 20399579
[TBL] [Abstract][Full Text] [Related]
5. Association of tumor location, extent of resection, and neurofibromatosis status with clinical outcomes for 221 spinal nerve sheath tumors.
Safaee M; Parsa AT; Barbaro NM; Chou D; Mummaneni PV; Weinstein PR; Tihan T; Ames CP
Neurosurg Focus; 2015 Aug; 39(2):E5. PubMed ID: 26235022
[TBL] [Abstract][Full Text] [Related]
6. Malignant peripheral nerve sheath tumors of the spine: results of surgical management from a multicenter study.
Chou D; Bilsky MH; Luzzati A; Fisher CG; Gokaslan ZL; Rhines LD; Dekutoski MB; Fehlings MG; Ghag R; Varga P; Boriani S; Germscheid NM; Reynolds JJ;
J Neurosurg Spine; 2017 Mar; 26(3):291-298. PubMed ID: 27834629
[TBL] [Abstract][Full Text] [Related]
7. Malignant peripheral nerve sheath tumor (MPNST) in the spine: a retrospective analysis of clinical and molecular prognostic factors.
Wang T; Yin H; Han S; Yang X; Wang J; Huang Q; Yan W; Zhou W; Xiao J
J Neurooncol; 2015 Apr; 122(2):349-55. PubMed ID: 25598015
[TBL] [Abstract][Full Text] [Related]
8. Hybrid schwannoma/perineurioma: clinicopathologic analysis of 42 distinctive benign nerve sheath tumors.
Hornick JL; Bundock EA; Fletcher CD
Am J Surg Pathol; 2009 Oct; 33(10):1554-61. PubMed ID: 19623031
[TBL] [Abstract][Full Text] [Related]
9. The Long-term Outcome After Resection of Intraspinal Nerve Sheath Tumors: Report of 131 Consecutive Cases.
Halvorsen CM; Rønning P; Hald J; Johannesen TB; Kolstad F; Langmoen IA; Lied B; Skaar Holme S; Helseth E
Neurosurgery; 2015 Oct; 77(4):585-92; discussion 592-3. PubMed ID: 26191976
[TBL] [Abstract][Full Text] [Related]
10. Cellular schwannoma. A clinicopathologic, DNA flow cytometric, and proliferation marker study of 70 patients.
Casadei GP; Scheithauer BW; Hirose T; Manfrini M; Van Houton C; Wood MB
Cancer; 1995 Mar; 75(5):1109-19. PubMed ID: 7850709
[TBL] [Abstract][Full Text] [Related]
11. Tumors of the peripheral nervous system: analysis of prognostic factors in a series with long-term follow-up and review of the literature.
Montano N; D'Alessandris QG; D'Ercole M; Lauretti L; Pallini R; Di Bonaventura R; La Rocca G; Bianchi F; Fernandez E
J Neurosurg; 2016 Aug; 125(2):363-71. PubMed ID: 26636382
[TBL] [Abstract][Full Text] [Related]
12. Malignant melanotic schwannian tumor: a clinicopathologic, immunohistochemical, and gene expression profiling study of 40 cases, with a proposal for the reclassification of "melanotic schwannoma".
Torres-Mora J; Dry S; Li X; Binder S; Amin M; Folpe AL
Am J Surg Pathol; 2014 Jan; 38(1):94-105. PubMed ID: 24145644
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors of patients with spinal chondrosarcoma: a retrospective analysis of 98 consecutive patients in a single center.
Yin H; Zhou W; Meng J; Zhang D; Wu Z; Wang T; Wang J; Wang P; Shi X; Wu S; Zhao J; Xiao J
Ann Surg Oncol; 2014 Oct; 21(11):3572-8. PubMed ID: 24833099
[TBL] [Abstract][Full Text] [Related]
14. Risk Factors for Recurrence of Surgically Treated Conventional Spinal Schwannomas: Analysis of 169 Patients From a Multicenter International Database.
Fehlings MG; Nater A; Zamorano JJ; Tetreault LA; Varga PP; Gokaslan ZL; Boriani S; Fisher CG; Rhines L; Bettegowda C; Kawahara N; Chou D
Spine (Phila Pa 1976); 2016 Mar; 41(5):390-8. PubMed ID: 26555828
[TBL] [Abstract][Full Text] [Related]
15. Clinical analysis of spinal stereotactic radiosurgery in the treatment of neurogenic tumors.
Shin DW; Sohn MJ; Kim HS; Lee DJ; Jeon SR; Hwang YJ; Jho EH
J Neurosurg Spine; 2015 Oct; 23(4):429-37. PubMed ID: 26140405
[TBL] [Abstract][Full Text] [Related]
16. Presacral multiple cellular schwannomas.
Ogose A; Hotta T; Hatano H; Kawashima H; Umezu H; Higuchi T; Endo N
Spine (Phila Pa 1976); 2003 Oct; 28(20):E426-9. PubMed ID: 14560099
[TBL] [Abstract][Full Text] [Related]
17. Benign-appearing Intraspinal Malignant Peripheral Nerve Sheath Tumors: Treatments and Outcomes of 14 Consecutive Patients.
Gong H; Zhang D; Wang D; He S; Yang X; Wei H; Xiao J
Turk Neurosurg; 2018; 28(6):983-988. PubMed ID: 29634079
[TBL] [Abstract][Full Text] [Related]
18. Morphologic and immunohistochemical features of malignant peripheral nerve sheath tumors and cellular schwannomas.
Pekmezci M; Reuss DE; Hirbe AC; Dahiya S; Gutmann DH; von Deimling A; Horvai AE; Perry A
Mod Pathol; 2015 Feb; 28(2):187-200. PubMed ID: 25189642
[TBL] [Abstract][Full Text] [Related]
19. Clinical, surgical, and molecular prognostic factors for survival after spinal sarcoma resection.
Sciubba DM; De la Garza Ramos R; Goodwin CR; Abu-Bonsrah N; Bydon A; Witham TF; Bettegowda C; Gokaslan ZL; Wolinsky JP
Neurosurg Focus; 2016 Aug; 41(2):E9. PubMed ID: 27476851
[TBL] [Abstract][Full Text] [Related]
20. Risk factors for recurrence and regrowth of spinal schwannoma.
Takahashi T; Hirai T; Yoshii T; Inose H; Yuasa M; Matsukura Y; Morishita S; Kobayashi Y; Utagawa K; Kawabata A; Hashimoto J; Tanaka T; Motoyoshi T; Hashimoto M; Kawabata S; Okawa A
J Orthop Sci; 2023 May; 28(3):554-559. PubMed ID: 35382954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
